DiscoverPharmaceutical ExecutivePharmaceutical Executive Daily: FDA Approves Wegovy Pill
Pharmaceutical Executive Daily: FDA Approves Wegovy Pill

Pharmaceutical Executive Daily: FDA Approves Wegovy Pill

Update: 2025-12-23
Share

Description

In today’s Pharmaceutical Executive Daily, the FDA approves Novo Nordisk’s oral Wegovy for chronic weight management, clears Roche’s Lunsumio Velo for adults with relapsed or refractory follicular lymphoma, and Alnylam announces a $250 million investment in a new Massachusetts manufacturing facility.
Comments 
In Channel
Pharmaceutical Executive Daily: FDA Approves Wegovy Pill

Pharmaceutical Executive Daily: FDA Approves Wegovy Pill

2025-12-2301:39

Pharmaceutical Executive Daily: Nine New Additions to TrumpRx

Pharmaceutical Executive Daily: Nine New Additions to TrumpRx

2025-12-2201:53

Scaling Sustainability: A Big Pharma Formula

Scaling Sustainability: A Big Pharma Formula

2025-12-2217:26

Pharmaceutical Executive Daily: US Senate Passes Biosecure Act

Pharmaceutical Executive Daily: US Senate Passes Biosecure Act

2025-12-1901:52

Pharmaceutical Executive Daily: Pfizer's Stock Drops Following 2026 Revenue Projections Release

Pharmaceutical Executive Daily: Pfizer's Stock Drops Following 2026 Revenue Projections Release

2025-12-1801:49

Pharmaceutical Executive Daily: FDA's Approval of Lerochol

Pharmaceutical Executive Daily: FDA's Approval of Lerochol

2025-12-1701:33

Pharmaceutical Executive Daily: TrumpRx's Critical Blind Spot

Pharmaceutical Executive Daily: TrumpRx's Critical Blind Spot

2025-12-1601:37

Pharmaceutical Executive Daily: Retatrutide's Positive Phase III Trial Results

Pharmaceutical Executive Daily: Retatrutide's Positive Phase III Trial Results

2025-12-1501:53

Pharmaceutical Executive Daily: FDA's Approval of Waskyra

Pharmaceutical Executive Daily: FDA's Approval of Waskyra

2025-12-1101:42

Pharmaceutical Executive Daily: FDA's New Standard for CAR-T Approvals

Pharmaceutical Executive Daily: FDA's New Standard for CAR-T Approvals

2025-12-1001:53

Pharmaceutical Executive Daily: Carvykti Demonstrates Sustained Remissions

Pharmaceutical Executive Daily: Carvykti Demonstrates Sustained Remissions

2025-12-0901:48

Pharmaceutical Executive Daily: FDA Approves Breyanzi

Pharmaceutical Executive Daily: FDA Approves Breyanzi

2025-12-0801:43

Pharmaceutical Executive Daily: Mark Cuban's Push for Generic Drug Fee Waivers

Pharmaceutical Executive Daily: Mark Cuban's Push for Generic Drug Fee Waivers

2025-12-0501:48

Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER

Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER

2025-12-0401:49

Pharmaceutical Executive Daily: FDA's Agentic AI Deployment

Pharmaceutical Executive Daily: FDA's Agentic AI Deployment

2025-12-0301:51

Pharmaceutical Executive Daily: Lilly Reduces the Price of Zepbound

Pharmaceutical Executive Daily: Lilly Reduces the Price of Zepbound

2025-12-0201:49

Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products

Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products

2025-12-0101:50

Pharmaceutical Executive Daily: Novartis Cuts 550 Jobs

Pharmaceutical Executive Daily: Novartis Cuts 550 Jobs

2025-11-2601:50

Pharmaceutical Executive Daily: Moderna's $1.5 Billion Loan

Pharmaceutical Executive Daily: Moderna's $1.5 Billion Loan

2025-11-2502:03

Pharmaceutical Executive Daily: Tesaro and AnaptysBio's Legal Battle

Pharmaceutical Executive Daily: Tesaro and AnaptysBio's Legal Battle

2025-11-2402:08

loading
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Pharmaceutical Executive Daily: FDA Approves Wegovy Pill

Pharmaceutical Executive Daily: FDA Approves Wegovy Pill

Pharmaceutical Executive Podcast